Search results
Results from the WOW.Com Content Network
[4] [examples needed] Treatment includes medications such as antacids, H2 blockers, or proton pump inhibitors. [1] During an acute attack drinking viscous lidocaine may help. [9] If gastritis is due to NSAIDs these may be stopped. [1] If H. pylori is present it may be treated with a combination of antibiotics such as amoxicillin and ...
Promotility drugs relieve symptoms of reflux by speeding the clearance of acid from the oesophagus and stomach. [1] The parent compound, erythromycin, has these characteristics, but mitemcinal lacks the antibiotic properties of erythromycin. [2] Presently, erythromycin is commonly used off-label for gastric motility indications such as ...
Stomach diseases include gastritis, gastroparesis, Crohn's disease and various cancers. [1] The stomach is an important organ in the body. It plays a vital role in digestion of foods, releases various enzymes and also protects the lower intestine from harmful organisms. The stomach connects to the esophagus above and to the small intestine below.
However, according to retrospective data, roughly one in seven patients with portal hypertensive gastropathy will develop bleeding (either acute or chronic) attributable to the gastropathy. [1] Patients with chronic bleeding will usually present with anemia. The diagnosis of portal hypertensive gastropathy is usually made on endoscopy.
This erythromycin treatment may lead to a small decrease in the need for a blood transfusion, but the overall balance of how effective erythromycin is compared to potential risks is not clear. [15] [23] Proton pump inhibitors, if they have not been started earlier, are recommended in those in whom high risk signs for bleeding are found. [15]
Erythromycin's elimination half-life ranges between 1.5 and 2.0 hours and is between 5 and 6 hours in patients with end-stage renal disease. Erythromycin levels peak in the serum 4 hours after dosing; ethylsuccinate peaks 0.5–2.5 hours after dosing, but can be delayed if digested with food. [39]
[13] [14] The disease tends to be less severe in developing countries, due to the constant exposure which people have with the antigen in the environment, leading to early development of antibodies. [12] Rotavirus is responsible for infecting 140 million people and causing 1 million deaths each year, mostly in children younger than five years.
Saccharopolyspora erythraea produces the macrolide antibiotic erythromycin. [2] Cytochrome P450 eryF (CYP107A1) originally from the bacterium is responsible for the biosynthesis of the antibiotic by C6-hydroxylation of the macrolide 6-deoxyerythronolide B. [3] [4]